Dr Ming-Han Lim

MBChB (Otago) FRACP



Consultant Gastroenterologist & general physician

 

Area of expertise:

  • Diagnostic and therapeutic endoscopy (gastroscopy and colonoscopy)
  • Inflammatory bowel disease (Crohn’s disease, ulcerative colitis, microscopic colitis)
  • Liver diseases
  • Bowel cancer screening
  • Anaemia and gastrointestinal bleeding (capsule endoscopy)
  • Coeliac disease
  • Dyspepsia and reflux
  • Functional bowel disease, irritable bowel syndrome, chronic diarrhoea, constipation

Qualifications:

  • MBChB (Otago) 2007, FRACP 2015

Training:

  • Undergraduate: Otago Medical School, University of Otago 2002-2007
  • Basic and advanced physician training: Gastroenterology and General Medicine 2008-2016
  • Post fellowship training: Senior inflammatory bowel disease fellow, Royal Brisbane and Women’s Hospital, Brisbane, Australia 2017-2018

Current employment:

  • Consultant gastroenterologist and general physician, Middlemore Hospital 2018

Additional language skills:

  • Mandarin, Cantonese, Teochew, Hokkien, Malay

Memberships:

  • New Zealand Society of Gastroenterology
  • Auckland Chinese Medical Association

Research:

Publications:

 2018  Lim MH, Radford-Smith GL. Editorial: First among equals – not for either infliximab or adalimumab in Crohn’s disease – yet. Aliment Pharmacol Ther 2018; 47 (8):1225-1226 
 2017 Lim MH, Aluzaite K, Schultz M, Casey P. Infliximab trough levels: a comparison between the Quantum Blue infliximab rapid assay and the established ELISA. Journal of Gastroenterology and Hepatology 2017; 32 (Suppl 2):132
 2017 Lim MH, Radford-Smith GL. Editorial: Faecal microbiota transplantation for ulcerative colitis – not quite there yet? Aliment Pharmacol Ther 2017; 46 (6):630-631
 2016 Lim MH, Faire B, Beban G, Orr DW. Reliability of transient elastography for the detection of fibrosis in severely obese patients. Hepatol Int 2016; 10:S1-S506
 2015 Lim MH, Phipps-Green M, Merriman T, Schultz M. Association of NOD2 mutations with disease phenotype in an Otago cohort of patients with Crohn’s disease. NZMJ 2015; 128 (1408)
 2014 Orr DW, Lim MH, McCall JL, Bartlett, Gane EJ. Years of liver transplant assessments for hepatocellular carcinoma: a single centre experience. Hepatol Int 2014; 8:S1-S405
 2014 Lim MH, Gane EJ, Orr DW. Years of liver transplant assessments for chronic liver disease: a single centre experience. Hepatol Int 2014; 8:S1-S405
 2014 Lim MH, Smith W, Larsen P. Is the risk/benefit ratio for cardiac defibrillators implanted in an older population (age ≥ 75) still favourable? NZMJ 2014; 127 (1388)
 2013 Lim MH, Gane EJ, Orr DW. Years of liver transplant assessments for chronic liver disease: a single centre experience. NZMJ 2013; 126 (1387)
 2013 Lim MH, Garrett J, Mowlem L, Yap E. Diagnosing malignant pleural effusions: how do we compare? NZMJ 2013; 126 (1381)

 

Oral presentations:

 2018  Australian Gastroenterology Week: Have changes in medical therapy and surgical techniques for ulcerative colitis altered post colectomy outcomes over the past 26 years?
 2017  New Zealand Society of Gastroenterology Annual Scientific Meeting: Infliximab trough levels: a comparison between the Quantum Blue infliximab rapid assay and the established ELISA
 2017  Australian Gastroenterology Week: Infliximab trough levels: a comparison between the Quantum Blue infliximab rapid assay and the established ELISA
 2016  New Zealand Society of Gastroenterology Annual Scientific Meeting: Large sessile high grade dysplastic colorectal polyps can be managed successfully endoscopically
 2015  New Zealand Society of Gastroenterology Annual Scientific Meeting: Reliability of transient elastography for the detection of fibrosis in severely obese patients
 2014  New Zealand Society of Gastroenterology Annual Scientific Meeting: Association of NOD2 mutations with disease phenotype in an Otago cohort of patients with Crohn’s disease
 2014  The Asian Pacific Association for the Study of the Liver: Years of liver transplant assessments for chronic liver disease: a single centre experience
 2014  The Asian Pacific Association for the Study of the Liver: Years of liver transplant assessments for hepatocellular carcinoma: a single centre experience
 2013  New Zealand Society of Gastroenterology Annual Scientific Meeting: 15 years of liver transplant assessments for chronic liver disease: a single centre experience
 2013  Cardiac Society of New Zealand Annual Scientific Meeting: Is the risk/benefit ratio for cardiac defibrillators implanted in an older population (age ≥ 75) still favourable?

 

Clinical trial experience:

Year  Trial name (Condition)   Role  Type  Phase
  2018   SHP647-302 (Ulcerative colitis)  Sub investigator  Industry  3
  2018  B7581002 (Ulcerative colitis)  Sub investigator  Industry  2a
  2017  RHB-104-01 (Crohn’s disease)  Sub investigator  Industry  3
  2017  PTG-100-02 (Ulcerative colitis)  Sub investigator  Industry  2b
  2017  GA29102 (Ulcerative colitis)  Sub investigator  Industry  3
  2017  GA28950 (Ulcerative colitis)  Sub investigator  Industry  3
  2017  GA28951 (Ulcerative colitis)  Sub investigator  Industry  3
  2017  GA29144 (Crohn’s disease)  Sub investigator  Industry  3
  2016  GA27927 (Ulcerative colitis)  Sub investigator  Industry  2/3
  2016  GS-US326-1100 (Ulcerative colitis)  Sub investigator  Industry  2/3
  2016  GS-US-395-1663 (Crohn’s disease)  Sub investigator  Industry  2
  2016  747-303 (Non alcoholic steatohepatitis)  Sub investigator  Industry  3
  2016  Heparc-2008 (Hepatitis B)  Sub investigator  Industry  2
  2016  ARC5211001 (Hepatitis B)  Sub investigator  Industry  1a/1b